Oncosil Medical Ltd (ASX:OSL)


OncoSil Medical Ltd is an innovative company for delivery of radiation therapy to patients.


Forrest Capital's Role:

Forrest associates were substantial shareholders in UK drug delivery company Enigma Therapeutics Ltd. The technology was originally discovered at The UK Department of Defence with circa $20 million invested to transaction date.

  • Forrest managed the acquisition of Enigma by OSL.
  • Funded the license agreement.
  • Facilitated the appointment of Dr Roger Aston to the board.
  • Raised $2 million for the initial transaction.
  • Raised $10 million in the follow-on capital raising as joint lead manager.

In June 2022 following the appointment of Mr Otto Buttula as Chairman Forrest acted as lead manager to a placement and rights issue raising a further $10 million to facilitate the commercialisation of Oncosil in the EU